Press Room

ISySyCat21

Start
Tuesday, August 31, 2021 - 09:00
End
Friday, September 03, 2021 - 09:00
Location: Evora, Portugal
ISySyCat21 - Hovione gold sponsor catalysis

Hovione is present at the International Symposium on Synthesis and Catalysis 2021 (ISySyCat2021) taking place at the University of Evora in the historically recognized mediaeval city of Evora from August 31st to September 3rd 2021.

The conference will be a mixed event, in person to be hold in Evora, Portugal (with a limited number of participants) and on-line (webinar). 

The conference will focus on key topics in contemporary organic, organometallic, polymer synthesis and catalysis, which are of relevance to both academic and industrial chemists alike. This is reflected in the topics that will be discussed in the plenary lectures.

 

 

Hovione will present a topic at the plenary lectures with the following details:

 

Natural potential: biocatalyzed asymmetric synthesis of chiral amines

The presentation will address the screening and optimization of biocatalysts for the synthesis of chiral amines of interest in the manufacture of APIs.

Presenter: Ágnes Lakó
Date: 31st August
Time: 3:15 pm - 3:30 pm

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025